Dimensional Fund Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,606,132
| Closed | -$25.3M | – | 3429 |
|
|
2024
Q1 | $25.3M | Buy |
1,606,132
+44,478
| +3% | +$685K | 0.01% | 1869 |
|
|
2023
Q4 | $25.2M | Buy |
1,561,654
+92,410
| +6% | +$1.18M | 0.01% | 1871 |
|
|
2023
Q3 | $18.7M | Buy |
1,469,244
+60,730
| +4% | +$838K | 0.01% | 1959 |
|
|
2023
Q2 | $19.8M | Buy |
1,408,514
+36,718
| +3% | +$525K | 0.01% | 1933 |
|
|
2023
Q1 | $21.2M | Buy |
1,371,796
+294,987
| +27% | +$4.93M | 0.01% | 1878 |
|
|
2022
Q4 | $17.6K | Buy |
1,076,809
+29,276
| +3% | +$476K | 0.01% | 1938 |
|
|
2022
Q3 | $19.4M | Buy |
1,047,533
+249,777
| +31% | +$3.92M | 0.01% | 1851 |
|
|
2022
Q2 | $10.5M | Buy |
797,756
+502,737
| +170% | +$5.55M | ﹤0.01% | 2167 |
|
|
2022
Q1 | $2.73M | Sell |
295,019
-2,526
| -0.8% | -$21.5K | ﹤0.01% | 2738 |
|
|
2021
Q4 | $2.91M | Buy |
297,545
+79,192
| +36% | +$1.49M | ﹤0.01% | 2744 |
|
|
2021
Q3 | $7.42M | Buy |
218,353
+121,800
| +126% | +$3.89M | ﹤0.01% | 2449 |
|
|
2021
Q2 | $3.54M | Sell |
96,553
-2,421
| -2% | -$93.7K | ﹤0.01% | 2706 |
|
|
2021
Q1 | $4.45M | Buy |
98,974
+40,447
| +69% | +$1.88M | ﹤0.01% | 2622 |
|
|
2020
Q4 | $3.34M | Sell |
58,527
-1,904
| -3% | -$113K | ﹤0.01% | 2657 |
|
|
2020
Q3 | $3.1M | Sell |
60,431
-404,271
| -87% | -$19.8M | ﹤0.01% | 2611 |
|
|
2020
Q2 | $27.8M | Sell |
464,702
-212,984
| -31% | -$11.4M | 0.01% | 1673 |
|
|
2020
Q1 | $27.9M | Buy |
677,686
+14,952
| +2% | +$830K | 0.01% | 1522 |
|
|
2019
Q4 | $41.2M | Buy |
662,734
+41,231
| +7% | +$1.96M | 0.02% | 1600 |
|
|
2019
Q3 | $21.1M | Buy |
621,503
+144,454
| +30% | +$4.28M | 0.01% | 1979 |
|
|
2019
Q2 | $10.8M | Buy |
477,049
+97,009
| +26% | +$2.27M | ﹤0.01% | 2365 |
|
|
2019
Q1 | $8.82M | Buy |
380,040
+173,425
| +84% | +$4.54M | ﹤0.01% | 2449 |
|
|
2018
Q4 | $4.34M | Buy |
+206,615
| New | +$5.08M | ﹤0.01% | 2654 |
|
Other funds holding DCPH
Dimensional Fund Advisors's DCPH Position: Q2 2024 in Review
Dimensional Fund Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 1,606,132 shares — an estimated $25.3M sold.
Dimensional Fund Advisors first reported a position in DCPH in Q4 2018 and held it in 22 quarters. The position peaked at $41.2M in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Dimensional Fund Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,606,132 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $25.3M.
- Dimensional Fund Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 22 quarters.
- Dimensional Fund Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $41.2M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Dimensional Fund Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.